Windtree Therapeutics, Inc. (WINT)

Windtree Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	4	7	45	87	137
Market Cap Growth	-59.82%	-43.61%	-85.53%	-47.73%	-36.55%	625.92%
Enterprise Value	1	1	3	26	74	120
PE Ratio	-	-0.18	-0.17	-0.67	-2.67	-4.98
PS Ratio	-	-	-	-	-	690.92
PB Ratio	0.12	1.09	0.66	1.08	1.25	1.83
P/FCF Ratio	-0.13	-0.28	-0.34	-1.89	-3.39	-5.50
P/OCF Ratio	-0.13	-0.28	-0.34	-1.92	-3.43	-5.55
EV/Sales Ratio	-	-	-	-	-	608.00
EV/EBITDA Ratio	-0.14	-0.05	-0.06	-0.34	-2.31	-4.65
EV/EBIT Ratio	-0.13	-0.05	-0.06	-0.33	-2.27	-4.46
EV/FCF Ratio	-0.05	-0.08	-0.13	-1.08	-2.87	-4.84
Debt / Equity Ratio	0.10	0.54	0.23	0.07	0.05	0.08
Debt / EBITDA Ratio	-0.28	-0.09	-0.06	-0.04	-0.12	-0.24
Debt / FCF Ratio	-0.11	-0.14	-0.12	-0.12	-0.15	-0.25
Quick Ratio	0.51	1.12	2.57	4.57	2.79	2.91
Current Ratio	0.67	1.35	3.00	4.77	2.96	3.05
Asset Turnover	0	0	0	0	0	0.00
Interest Coverage	-113.65	-404.82	-764.57	-679.90	-259.53	-54.51
Return on Equity (ROE)	-62.90%	-275.10%	-192.80%	-112.60%	-43.60%	-44.10%
Return on Assets (ROA)	-17.10%	-56.30%	-76.50%	-70.00%	-27.60%	-25.20%
Return on Capital (ROIC)	-123.11%	-394.50%	-336.26%	-172.60%	-41.34%	-30.64%
Earnings Yield	-323.82%	-548.17%	-597.34%	-149.07%	-37.52%	-20.08%
FCF Yield	-754.00%	-363.41%	-293.35%	-52.77%	-29.50%	-18.17%
Buyback Yield / Dilution	-868.75%	-515.24%	-27.27%	-58.11%	-43.25%	-629.69%
Total Shareholder Return	-868.75%	-515.24%	-27.27%	-58.11%	-43.25%	-629.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).